Pharma.Aero publishes UAV project white paper

0
85
Pharma.Aero publishes the UAV project white paper


Pharma.Aero has published the white paper of the latest UAV Project phase that explored the use of drones (UAVs) and its potential as part of the Life Science and Medtech logistic chain, thus interconnecting the traditional and modern airfreight worlds.

In the final part of the project (WP3), the project team investigated an industry case that includes drones in the multimodal process of transporting vaccines with strict cold-chain requirements from the factory in Europe to patients in hard-to-reach regions of Malawi.

Timeline Description automatically generated

In remote areas of Africa, it often takes three days to deliver medicines (by canoe) or to pick up a blood sample and take it to the lab. A drone can do it in less than an hour. In many places in Africa, it takes 4 hours to deliver Oxytocin in an emergency, when the life of a mother giving birth is at risk. A drone can save her life in under 20 minutes.

Read more: Rhenus Group and KatalX join Pharma.Aero

The lifesaving drones have become a common sight in remote areas of Africa, where people have little if any access to the health care they need and deserve. From the first drone flight on the continent, in 2016, to the world’s first drone delivery of a COVID vaccine with strict cold chain requirements, in Ghana, Africa has proven to be a global leader in the field of drones.

In 2021, Pharma.Aero initiated a project to further explore the drones’ potential as part of the Life Science and Medtech logistic chain, thus interconnecting the traditional and modern airfreight worlds.

What is the next step in pharma transportation by drone? Is it possible, feasible and safe to scale up drone delivery and make it more affordable and sustainable for use in the public health sectors of low- and middle-income countries? How can we better integrate drones into the supply chains?

Read more: Abu Dhabi International Airport joins Pharma.Aero

Pharma.Aero has taken the lead in exploring all these aspects through the UAV Project. The results are now shared with the industry by the publication of the White Paper.

The project’s goal is to offer unprecedented insights by mapping the vaccines’ journey from factory to patients and explore modalities of further integrating the drones. The project team investigated potential directions of optimising the logistics, thus identifying relevant aspects and factors to be taken into consideration for further research on how and where UAVs are most valuable to the supply chain system.